Mycobactin is the name suggested for a growth factor, present in acid-fast bacteria, which is essential for the growth of Mycobacterium johnei. A preliminary account ofthe work reported here has already been published (Francis, Madinaveitia, Macturk & Snow, 1949) . Myco. johnei is an organism first observed by Johne & Frothingham (1895) in cases of chronic enteritis of cattle. It could not be cultivated on ordinary laboratory media. Twort & Ingram (1913) supplemented such media with various extracts of normal cattle tissues, but none produced growth. They postulated that failure to cultivate the bacillus 'must be due to the absence of some necessary foodstuff', and that the missing factor would most likely be found in tubercle bacilli. They showed that when dried, killed, human tubercle bacilli were added to egg medium, a good growth of Myco. johnei developed. They were also able to obtain growth by addition of killed cells of other mycobacteria which had been grown on suitable media, and even by addition of cells of Myco. johnei which had been acclimatized to grow on beef broth without added growth factor. They made the original suggestion that the specific growth substance was essential to the metabolism of the whole group of acid-fast organisms, Myco. johnei differing from the other mycobacteria in lacking the power to initiate synthesis of this factor on an egg medium. This hypothesis has been reinforced by the subsequent discovery of many parallel cases in other families of organisms where some members can synthesize a particular factor while others require the same factor to be supplied from an external source. For example, among the Lactobacilli Lb. casei, Lb. delbruckii and Lb. Iactis have been shown to require pyridoxine for growth, whilst Lb. arabinosu8 and Lb. pentosus synthesize pyridoxine (Bohonos, Hutchings & Peterson, 1942) .
Twort & Ingram prepared extracts of mycobacteria with organic solvents and found that they promoted the growth of Myco. johnei. This observation was one of the earliest indications of the existence of a specific organic growth factor for a micro-organism, and was made at a time when even * Present address: Department of Preventive Medicine, University of Queensland Medical School, Brisbane. the concept of vitamins was novel. Although simple extracts of Myco. phlei have been used regularly for the purpose of culturing Myco. johnei, the literature contains no record of any further attempt to concentrate and isolate the active substance. Woolley & McCarter (1940) claimed that growth of Myco. johnei on liquid medium could be promoted by phthiocol or 2-methylnaphthaquinone, but the amount of growth observed was less than that given by addition of extracts of Myco. phlei. They gave no evidence of the occurrence of quinones in Myco. phlei. Francis et al. (1949) found no phthiocol in Myco. tuberculos8i, though a substance resembling vitamin K2 was present in considerable amounts. Considering that the growth factor in Myco. phlei may well represent an important and specific component in the metabolism of mycobacteria, it is surprising that no further attempt has been made to investigate its constitution. The preparation of chemotherapeutic agents against this group of organisms might well be helped by a knowledge of the chemical structure of the growth factor. The extraction and purification of the factor was therefore undertaken, and the results are presented in this paper. The experiments have led to the isolation of the hitherto undescribed compound, mycobactin, which has the growth-promoting action of the original extracts; its main properties are outlined here. RESULTS Extraction and purification of mycobactin Growth of Myco. phlei for mycobactin extraction. Twort & Ingram (1913) showed that the growth factor was produced by a wide range of mycobacteria grown on glycerol beefbroth. The organisms tested included Myco. phlei, Myco. tuberculosis, Myco. smegmatis and Myco. butyricum, as well as certain other less well-defined acid-fast bacteria. Of these the first two were regarded as the best sources, and bovine and avian strains of Myco. tuberculos8i were said to be much inferior to human strains; this distinction was not confirmed by McFadyean, Sheather & Edwards (1912) . None ofthe organisms, however, produced detectable amounts of the growth factor when grown on glycerol-liver broth, 596 MYCOBACTIN and,except with humanstrains, production ofgrowth factor was low or absent on egg medium. Twort & Ingram were therefore fortunate in having chosen cultures of human strains for their original experiments.
In the present investigation the non-pathogenic, readily cultivated Myco. phlei was chosen as a source of the growth factor. Large quantities of the bacterial cells were required, and it would have been convenient if these could have been grown on a synthetic medium. Although good growth of Myco. phlei was obtained with glycerol-containing media having as a source of nitrogen asparagine (Green, 1946) , ammonium malate or peptone, the content of mycobactin in the cells was negligible; addition of yeast extract ('Marmite') did not affect the result. It was therefore necessary to turn to the less convenient beef infusion medium. An infusion containing 4 % peptone and 10 % glycerol (twice the normal concentrations) gave the best results in bacterial growth and yield of mycobactin, and was used for all the large-scale cultivation of Myco. phlei. It may be noted that this more concentrated medium is unsuitable for the growth of tubercle bacilli.
Establishment of an assay method. The assay of the growth factor required a method of cultivating and assessing the amount of growth of Myco. johnei. Solid egg medium was chosen because irregular results were obtained when attempts were made to obtain growth of pellicle on the surface of fluid media. Egg medium was a more suitable material than liquid medium in which to emulsify the original crude extracts; moreover, many of these extracts would have had a surface-active effect and might have caused the pellicle to sink. To determine the best conditions for the assay of mycobactin, Myco. johnei was grown on solid egg medium containing varying amounts of the factor. Fig. 1 shows the average of a large number of such experiments, in which the concentration of mycobactin has been correlated with the mean growth score after various time intervals. This diagram shows the main features of the growth of Myco. johnei under the chosen conditions. In the presence of high concentrations of mycobactin there is a 'rapid' growth period during the second to eighth week of incubation, after which the growth rate becomes much less. When a smaller amount of the factor is present the lag phase is slightly longer and subsequent growth occurs more slowly, though it continues for a long period. Experiments were also carried out in which growth was measured up to 36 weeks. These showed that the differential growth response for varying concentrations of mycobactin became less as the time increased, because growth at high concentrations had almost ceased, whilst that at lower concentrations was still continuing. It was thus evident that the best time to assess the amount of growth was after 4-6 weeks' incubation. Shorter periods did not allow sufficient growth for assessment and longer periods gave no improvement in the ratio of growth response to mycobactin concentration, or even, in very prolonged experiments, a decrease in the ratio. Extraction methods. The work of Twort & Ingram (1913) indicated that the growth factor could be extracted from the bacterial bodies by a variety of organic solvents. Exploratory experiments confirmed these findings and acetone was chosen as the solvent for the early experiments. Acetone extracts were more active than the bacterial bodies from which they originated; this is presumably due to the non-availability of the growth factor present inside the bacterial cells. Presumably it also explains the finding that no great loss of activity resulted when the bacterial bodies were heated with sodium hydroxide solution, although extracts lost their activity when treated with alkali, even at 00. Light petroleum extracted very little activity from the dried bodies, and addition of light petroleum to the concentrated acetone extracts produced a precipitate which contained the whole of the active materials. This proved to be a most important step because, although it was not realized at the time, the precipitate contained up to 50 % of mycobactin.
The light-petroleum precipitation was followed by an extraction with water which removed further inactive impurities. At this stage it was found that the growthfactor was stronglyadsorbedbyalumina, from which it could be eluted by hot ethanol. Repeated extractions with hot ethanol removed the active materials. On concentration of these eluates mycobactin separated as a crystalline aluminium complex, the aluminium having been derived from the adsorbent. the metal-free material that have been made, repeated purification has always led finally to products having the same melting point and ultraviolet-absorption spectrum, with analyses consistent with those found for the aluminium complex. Measurements of optical rotation, however, have been more variable, and there is a possibility that some strongly rotating impurity may be present in varying amounts in some of our preparations. The value given for the rotation in the experimental section is that found for the most rigorously purified preparations. The possibility of error in rotation measurements is evident when the very high positive rotation of the aluminium complex is considered. The presence of 0-3 % of this derivative would lower the specific rotation of the metal-free product by 10. In view of the amorphous character of the material and the occasional discrepancy in optical rotation, some caution is necessary in assessing the purity ofthe preparations ofmetal-free mycobactin. Degradation studies, which will be described in later papers, favour the view that metal-free mycobactin is substantially a single substance, but do not exclude the possibility that some preparations might contain a few per cent of a closely related product. The diacetyl derivative and copper complex of mycobactin are directly derived from the metal-free product and resemble it in lacking visible crystalline structure; they therefore probably reflect any degree of inhomogeneity which may be present in the mycobactin from Owing to the large molecular size it is not possible to deduce this formula from the analytical figures for mycobactin alone. The formula takes into account the analytical data for all the derivatives of mycobactin, molecular-weight and equivalent-weight determinations, and the degradation products which have been isolated; the latter will be described in a later paper. This formula differs somewhat from that postulated in our preliminary note (Francis et al. 1949) . The difference is mainly due to difficulties of nitrogen analysis, the early values being considerably too high. Molecular-weight determinations by the usual physical methods have proved unreliable, but X-ray measurements upon a single crystal of the aluminium complex have indicated a unit-cell weight of 1828 + 4 %. From considerations of crystal structure the molecular weight was considered to be one-half or one-quarter of this figure; this corresponds to a molecular weight of 890 + 36 or 445 + 18 for metal-free mycobactin, assuming that the crystalline derivative has one atom of aluminium per molecule of mycobactin. The lower figure is, however, excluded by equivalent-weight determination (see below) and by the degradation products.
Acidic and basic properties. Mycobactin is a weakly acid substance. Electrometric titration in methanol gives the curve shown in Fig. 3 ; a curve for the titration of p-chlorophenol is given for comparison. The titration data show that mycobactin has one or possibly two acidic groups dissociated in methanol to an extent comparable with the phenols. No basic groups can be detected by titration with hydrochloric acid in methanol, but by use of perchloric acid in glacial acetic acid the presence of one weakly basic group can be demonstrated. The equivalent weight of mycobactin as a base can thus be determined; the value found, 870 ± 4, also represents the molecular weight. The basic properties of mycobactin are further shown by the formation under anhydrous conditions of a hydrochloride and a picrate. The slightly impure hydrochloride has an absorption spectrum similar in shape to that of the parent compound, but with the peaks shifted approximately 20 m,. towards the longer wavelength (see Fig. 2 ). This shift indicates that the basic group is probably in conjugation with the system responsible for the absorption.
Metal complexes. Copper mycobactin is almost insoluble in cold ethanol; it is formed from mycobactin by precipitation with ethanolic cupric acetate. It has little solubility in most solvents at room temperature, except chloroform in which it dissolves to the extent of more than 5 % giving a deep-green solution.
Copper can be removed from the complex bytreating the chloroform solution with hydrogen sulphide, by extracting it with N-hydrochloric acid, or by passage through cation exchange resin in the acid form.
Both copper and aluminium complexes have ultraviolet-absorption spectra resembling that of the parent compound except that the peaks are raised and displaced to longer wavelengths (see Fig. 2 ). Ferric salts react with mycobactin to give an intense reddish purple colour.
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HydroXy1 groups. Two acetyl groups can be introduced into mycobactin under gentle conditions of acetylation. No degradation ofthe molecule appears to occur as a result of this treatment since the spectrum is not significantly changed (see Fig. 2 ), and the product still possesses growth-promoting properties. The diacetate is an amorphous powder resembling mycobactin in its fluorescence and other physical properties; it has a reproducible melting point. It differs from mycobactin in forming neither a crystalline aluminium complex nor an ethanol-insoluble copper complex. Ferric chloride in ethanol produces an intense violet colour, noticeably bluer than that given by mycobactin. It has weakly acidic properties shown by its solubility in sodium hydroxide solution, but the acidic group is too weak to be demonstrable by electrometric titration in methanol (see Fig. 3 ). The weak basic group found in mycobactin is also present in the diacetate. Since the titration of mycobactin has shown the absence of any basic groups strong enough to form a hydrochloride in polar solvents, it may be inferred that acetylation takes place in two hydroxyl groups. At least one of these groups is acidic and is involved in metal complex formation. In addition to these two hydroxyl groups there is probably a third having phenolic properties and not readily acetylated. This is suggested by the ferric chloride reaction and the weakly acidic properties of the diacetate. Further, both mycobactin and its diacetate couple in alkaline solution with diazonium salts to give yellow solutions.
Vigorous acetylation leads to the uptake of acetic anhydride corresponding to three acetyl groups per molecule, but the reaction brings about a great change of properties and probably involves -degradation. EXPERIMENTAL Large-scale production of Myco. phlei. A beef-infusion broth was prepared containing 4 % peptone and 10 % glycerol. 600 ml. portions were transferred to a series of plugged Winchester bottles and sterilized. The bottles were stacked on their sides and pellicles from an established culture floated on to the surface with a wire loop, and then incubated for 2 weeks at 32-37°. The pellicles were harvested by filtration on a large stoneware filter, well washed with water and sucked as dry as possible. The yields obtained were usually just over 2 g. dried organisms/100 ml. of medium. In all, 50-60 kg. of dried bacterial bodies have been produced. Mycobactin formation by Myco. phlei grown on various media. The media contained K2HPO4 1-8 g., MgSO4, 7H20 0-5 g., sodium citrate 0-9 g., Fe2(SO4)3, 9H20 0-2 g., glucose 10 g. and glycerol 100 g. To this 14g. asparagine or 10 g. peptone, or 12-52 g. malic acid neutralized with NH3 was added. The volume was made up to 11. in each case and the pH adjustedto6-8. Inocula of Myco. phlei from culturesadapted to thesemediabyfivepassages were floated in lOml.medium placed in wide tubes and incubated at 37°. The amount of bacterial nitrogen was estimated every other day. After 12 days it had reached a maximum in all media. Bacteria from all these media failed to support the growth of Myco. johnei, whereas bacteria grown in a parallel experiment in meat-infusion broth with 5% glycerol were active in this respect. The amounts of 'bacterial nitrogen' produced (in mg./ml. medium) in the various media were: asparagine (1-68), ammonium malate (1-15), peptone (0-80) and glycerol broth (0-62).
Assay of growth-promoting activity. Egg-liver medium was prepared according to the directions of Dunkin (1928) , the standard glycerol-water extract of Myco. phlei being replaced by the extract which was being tested. The active extracts were insoluble in water; they were dissolved in the least possible amount of acetone, methanol or CHC13 and an appropriate amount put in the first tube. Egg medium was pipetted vigorously on to the fraction and the mixture shaken. A satisfactory dispersion resulted and falling 2-5-fold dilutions were made; five tubes were prepared from each dilution. Other tubes contained known amounts of a standard concentrate, or, in later experiments, known amounts of mycobactin; tubes containing no growth factor were also included in every test. The medium was inspissated to give steep slopes, during which process any solvent used to dissolve the growth factor was driven off. The tubes were inoculated with a pinhead inoculum ofstrain 129, which had been supplied by Prof. R. E. Glover as a strain of Myco. johnei which could not easily be adapted to grow in the absence of growth factor. Cotton-wool plugs were dipped in wax, pushed into the tubes and covered with a layer of wax. This precaution was needed to prevent loss of moisture. The tubes were incubated at 370 and growth estimated visually after 4 and 6 weeks. An optimum quantity of growth factor (equivalent to 40-80,ug. mycobactin/ml. of medium) produced a raised, irregular mass of bacteria roughly circular and up to 6 mm. in diameter. The minimum recognizable growth promotion was produced by a concentration of mycobactin of about 0-5 to 1 ,g./ml. of medium; 1000l,g./ml. did not inhibit growth. A method of scoring was adopted which recognized six stages between absence of growth and optimumgrowth, andthese were given values of 3, 2-5, 2-0, ..., 0. Some extracts of Myco. phlei produced inhibition of growth at concentrations above the optimum. From 
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Below this the whole column retained a light-green colour. The top band was then scraped out and the residual copper complex eluted from the lower part of the column with 20 % (v/v) ethanol in CHC13 (1 1.). This last effluent was collected separately, combined with a small fraction representing the overlap between the main band and the lower brown band, and evaporated. The residue was dissolved in CHC13 and applied to a smaller Decalso column treated exactly as before. Fractions from this second column were bulked with corresponding fractions from the larger column. These fractions were then evaporated. Another small fraction was obtained by eluting the dark band from the top of the Decalso columns with 50% (v/v) ethanol in CHCl3. The overall result is shown in Table 5 .
Both silica gel and Decalso may be recovered for further use provided that the top 2-3 cm. containing strongly adsorbed material is discarded. The adsorbent should be well washed with 50 % (v/v) CHCl3 in ethanol and dried at 1500 before using again. Final purification of mycobactin. The Cu complex purified by chromatography (fraction N) was dissolved in CHC13 (20 ml./g.), and dry ether (3 vol.) added slowly with stirring. The precipitated Cu complex was filtered, redissolved in CHCI3 and the precipitation repeated. It was then washed three times with ether by resuspension and finally filtered and dried in dry air. This precipitation achieved a further slight purification, and yielded Cu mycobactin (P) as a grey-green powder convenient to handle. The combined filtrates on evaporation gave fraction o, a green, resinous solid.
The complex (50 g.) was dissolved in CHC13 (1 1.) and redistilled methanol (2-5 1.) added. Washed H2S was passed through the solution until all Cu had been converted into sulphide; air was then blown through to remove excess H2S. The solution was filtered and the precipitate well washed with CHC13.
The pale-yellow filtrate usually contained a little colloidal CuS. It was evaporated and the residue dissolved in CHC13 (11.). The solution was applied to a short column made by suspending pure anhydrous MgSO4 (40 g.) in CHC13 in a 5 cm. diameter tube. The column was then washed with CHC13 (250 ml.). The CuS was removed as a thin black layer on top of the column and there was also a faint-brown band of some other impurity below.
The solution passing through the column was filtered, evaporated to about 700 ml., and the mycobactin precipitated by the addition of redistilled ether (1.8 1.). The precipitate was filtered off, washed with dry ether and dried in air. The product R from this method of extraction was usually faintly yellow but was suitable for most purposes. Evaporation of the filtrate gave a fraction q. Additional purification of fraction R could be achieved by repeated precipitation with ether, and the following method was found useful for removing traces of colour. Mycobactin (2 g.) was dissolved in dry methanol (100 ml.) and water (3 ml.) added slowly with stirring. No immediate precipitation occurred, but after standing overnight at room temperature a gelatinous precipitate settled out. This was filtered off and dried (0.48 g.). Most of the colour was adsorbed in this precipitate, and on addition of more water (5 ml.) the remainder of the mycobactin was precipitated as a colourless jelly, which gave on drying a white powder (1.42 g.).
Activity of side fractions. Fractions a, d, f, j and I had no growth-promoting activity, whilst the amount of mycobactin in fractions b, h and i was too small to make their purification worth while; fractions o, m and q were kept for recycling.
Alternative extraction procedures. The method described above involves considerable labour in the early stages. In some experiments water was removed from the cells by drying in a ventilated oven at 75°. The product was then milled and extracted repeatedly with hot acetone. After removal ofinactive material which settled out on cooling the solution, the solvent was removed and the residue was ground with light petroleum in a mortar. Successive extractions with this solvent yielded a dry brick-red powder containing most of the mycobactin and a very dark syrup which was soluble in water and couldthus be separated from the required product. It was possible to proceed from this stage to the direct isolation of a crystalline aluminium complex.
The crude product obtained as described above (2-5 g.) was dissolved in CHCl3 (50 ml.) and applied to a 3 cm. column containing 100 g. neutral A1203. The colunn was washed successively with 2, 5 and 10% (v/v) ethanol in CHCl3. The washings removed coloured impurities. The columnretained a series of brownish bands and a broad zone fluorescing blue in ultraviolet light. The latter zone was removed and eluted by refluxing with ethanol (3 x 150 ml.). The brownish ethanolic extract was concentrated to small bulk and allowed to stand, when crystals of crude Al mycobactin separated (0-40 g.). The crystals were purified by repeated crystallization from ethanol or acetone, finally giving a product, m.p. 214-215°. The crystals obtained in this way were always reddish brown, the amount of colour varying from one preparation to another. A typical analysis gave C, 62-7; H, ; N, 7-85; Al, 2-5 %. Metal-free mycobactin could also be prepared from the crude product described above. For this purpose it was first purified by passing a CHC13 solution through short columns of MgSO4 which absorbed some dark-coloured tars. After removal of the solvent, the residue was treated successively with ether and benzene, to take out impurities soluble in these solvents. This gave a light-brown powder suitable for conversion into the Cu complex and treatment by methods already described.
In most of the large-scale preparations that have been carried out, Cu was removed by treatment with H2S, but 604 I953 Vol. 55 
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this method was somewhat unsatisfactory owing to the tendency to formation of colloidal CuS and to some contamination of the product with sulphur compounds. The use of ion-exchange resin was subsequently found to be advantageous, although there was some loss of product due to adsorption on the resin. Dry Zeo-Karb 225 in the acid form was ground in a Christie and Norris mill to pass a 200-mesh sieve and washed free from fine particles by repeated settling in ethanol with removal of the supernatant. The resin (90 g. dry wt.) was allowed to settle in a 2-5 cm. tube andtheethanolwas displaced by4O% (v/v) CHCl3in ethanol. Cu mycobactin (20 g.) in the same solvent (15 1.) was allowed to flow through the column (time required, approx. 24 hr.) and the column washed with the solvent (500 ml.).
The issuing solution was free from copper and evaporation gave mycobactin (15 g.). The resin could be recovered by passing through it 2x-HCI in ethanol.
Analytical method8
Melting points are corrected. Spectra were measured on a Beckman spectrophotometer (cell length 2 cm. unless otherwise stated).
Electrometric titrations in methanol. The electrode assembly cpnsisted of a glass electrode conditioned to the solvent, and a reference electrode of Hg-HgCl-2m-methanolic-LiCl connected with the titration cell by a capillary bridge containing LiCl solution. Titration was carried out in a cell of 3 ml. capacity with magnetic stirring, the alkali solution being added from a micrometer syringe. The solvent used was methanol containing 20% (v/v) CHC13 to increase the solubility of mycobactin. Readings were made on the pH scale of theinstrument, but owingtothenature of the solvent used the results are arbitrary and have no significance in terms of pH. The magnitude of the readings was found to vary somewhat from one experiment to another, though the form of the titration curve remained the same. In plotting the results the readings have been adjusted so that the maximum reading is the same in each case.
Titration of weakly basic group8. Approx. 100mg. of mycobactin or a derivative dissolved in 5 ml. glacial acetic acid was titrated with 01 M-HC104 in glacial acetic acid using crystal violet as indicator (Nadeau & Branchen, 1935) . The solution was standardized against 5 ml. 0-04M-ptoluidine in glacial acetic acid under exactly similar conditions.
Quantitative acetylation. The substance (0-05-0{08 mequiv.) was weighed into a 10 mm. tube. Acetic anhydride in dry pyridine (IM, 0-1 ml.) was added from a micrometer syringe and the tube at once sealed. The tube was immersed 1 hr. in a boiling-water bath, then cooled, opened, and tube and contents transferred to a 25 ml. conical flask. Water (2 ml.) was added and the residual acetic acid titrated with 0-03N-NaOH using phenolphthalein as indicator. Blank determinations were carried out under identical conditions. In the case of substances having an acid group, additional controls were included in which the substance was dissolved in pyridine and titrated with alkali as before; the acid equivalent was then used to correct the acetic acid titration.
General properties and derivatives
Mycobactin. The product obtained from the extractions described above was a white powder, not visibly crystalline.
Mycobactin had m.p. 165-166.50 : 870; 868; 873. (Found: C, [64] [65] H, N, . Tests for S, halogens, P and -OCH3 negative, ash absent. C47H75s00N requires C, 64-9; H, 8-7; N, 8-05%.) Salts ofmycobactin. For conversioninto the hydrochloride, mycobactin (1 g.) was dissolved in absolute CHCl3 (25 ml.) and dry ether (50 ml.) added with stirring. No immediate precipitation occurred. The solution was quickly cooled in an ice bath and dry HCI passed through the solution. The gelatinous precipitate of the hydrochloride was centrifuged, washed three times with dry ether and dried in a vacuum desiccator. The hydrochloride was not obtained wholly pure. The product was a white, amorphous powder of indefinite melting point ( For preparation of the picrate, mycobactin (1 g.) was dissolved in absolute CHCl3 (30 ml.) and treated with picric acid (0-4 g.) in CHC13 (20 ml.). Ether (140 ml.) was added and the yellow precipitate washed with ether, filtered and dried, giving 0-90 g., m.p. 146-1470. It was further purified by reprecipitating twice from CHCI3 by addition of ether. The product, still slightly impure, was a yellow powder without visible crystalline structure, m.p. 150-152°.
(Found: C, 58-4; H, 7-4; N, 9-7. C47H75010N5, C6H307N3 requires C, 57-9; H, 7-2; N, 10-2%.)
Aluminium mycobactin. The conversion of mycobactin into its Al complexmaybe brought about by adsorption on to neutral A1203 and subsequent elution with ethanol as described on p. 604. This procedure, however, always gives a brown product, possibly due to the uptake of traces of Fe from the adsorbent. Colourless crystals may be prepared by the use ofAl i8opropoxide, though the yields are low. Losses occur through the formation of an insoluble by-product, possibly polymeric. Mycobactin (1 g.) was dissolved in CHCl3 (20 ml.). One equivalent ofAl isopropoxide (0.235 g.) dissolved in CHCl, (5 ml.) was added, and the mixture allowed to stand overnight at 200. The solution was evaporated to small bulk (1-2 ml.) and an excess of ether (50 ml.) added. The solution was allowed to stand 6 hr. and then filtered from some flocculent precipitate (0.20 g.). The filtrate was evaporated and the residue dissolved in warm ethanol (3 ml.), filtered, and allowed to crystallize. Yield , H, [7] [8] [9] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [7] [8] [9] N, 795, [7] [8] [9] Al, C47H7201ON5Al requires C, 63-1; H, 8-1; N, 7-8; Al, 3.0%.)
Single crystal oscillation X-ray photographs were taken by Miss Bailey and Dr A. P. Wells, who report the following:
'The crystals are monoclinic and layer line measurements give (a) = 15-81±0-11; (b) = 12-31+0-11; (c) = 13-54+0-1.
Angle P = 101.50+ 10. Density by flotation in NaI solution, 1-175. Mol. wt. per unit cell= 1828 (+4%). The dimensions given are the mean offour determinations, but the accuracy is somewhat low owing to the form of the product which crystallizes in thin, fragile plates.'
For conversion of Al mycobactin into the metal-free compound, the crystalline product (1 g.) was dissolved in ethanol (20 ml.), and cupric acetate (0-2 g. monohydrate) in ethanol (10 ml.) added; the Cu complex was slowly precipitated on standing. After 6 hr. the complex was filtered, washed with ethanol and dissolved in CRC18 (20 ml.) 64'05, 63.95, 64-3; H, 8.35, 8.2, 8-15; N, 7.65, 7.7, 7.7. C51H79012N5 requires C, 64-2; H, 8*3; N, 7.3 %.) DISCUSSION The isolation of mycobactin reported here forms a preliminary to degradative work leading to determination of its structure which will be discussed in later papers. The properties at present reported show that mycobactin is a compound entirely different from any other known growth factor.
Mycobactin occurs in -relatively high concentrations (1 % of dry weight) in Myco. phlei grown on suitable media, and its biological activity accounts for most if not all of the growth-promoting action towards Myco.johnei possessed by simple extracts of Myco. phlei. Mycobactin or some related compound is probably present also in Myco. tuberculo8si and other mycobacteria which are known to promote I953 the growth of Myco. johnei. Proof that mycobactin itself is responsible for these effects will have to await the isolation of the growth factors from these organisms.
The question arises whether mycobactin is a compound found only in the mycobacteria or whether it has a wider distribution. The rather dubious growth stimulation of Myco. johnei by extracts of a variety of plant and animal tissues might indicate the presence of minute amounts of mycobactin, but could well be due to quite unrelated substances. There may be small amounts of mycobactin in the intestine which are not readily detected by the method of assay but the fact that Myco. johnei grows in the intestinal mucosa and mesenteric glands of the ox does not prove this to be true. It is probable that Myco. johnei can synthesize mycobactin when growing in vivo just as adapted strains may do when growing on synthetic medium.
Most of the known growth factors are of widespread occurrence, being found both in animals and in micro-organisms. Each compound of this kind probably has a characteristic biochemical function which is similar in different organisms even when they are of the most diverse types. This universality of function represents the biochemical unity underlying many living processes. Superimposed on these fundamental reactions, there are presumably certain metabolic reactions specific to particular organisms or groups of organisms leading to the production of characteristic compounds not found in other organisms. Thus, some peculiarity in the metabolism of the mycobacteria results in the production of fatty products having structures unusual among naturally occurring compounds. Little is known of the mechanism of such metabolic peculiarities. If mycobactin proves to be a growth factor specific to the mycobacteria in occurrence and action, it will be of unusual interest as an essential link in a type of metabolism confined to this particular genus. It may therefore have a special importance in relation to chemotherapy. Many attempts have been made to prepare synthetic drugs having chemical structures resembling those of known bacterial growth factors in the hope ofbringing about bacteriostasis bythe blocking of essential enzyme systems. Generally speaking these attempts have been unsuccessful in producing drugs of practical importance. The reasons for the failure appear to be due largely to the fact that most known growth factors for micro-organisms are also important substances in human metabolism. The result is that bacteriostatic drugs of this kind are often too toxic to be of chemotherapeutic value. An example of this effect is found in pyrithiamine, a structural analogue of thiamine (Woolley & White, 1943a, b (McIlwain & Hawking, 1943) . The failure of this substance as a drug may be attributed to the presence ofpantothenic acid in the body ofthe host in a concentration sufficient to nullify the action ofthe drug. There is reason to hope that these difficulties would not arise with drugs designed to simulate some feature of the mycobactin structure. Such drugs might prove of importance in the chemotherapy of tuberculosis or leprosy.
SUMMA]RY 1. Methods for large-scale production of Mycobacterium phlei are described: the organism contained large amounts of growth factor for Myco. johnei when grown on media made from beef, but not on other media.
2. A method for the assay of the growth factor is described.
3. The factor has been isolated as a crystalline aluminium complex and also in an amorphous metal-free form. The name 'mycobactin' is suggested for the compound.
4. Mycobactin is a hitherto undescribed compound. Evidence is given in support of the empirical formula C47H7500N5. Details are given of its general properties and of a number of derivatives.
5. The concentration of mycobactin in living Myco. phlei grown on beef infusion medium is estimated to be about 3 mg./g. Optimum growth of Myco. johnei is promoted by the presence of 40-80 ,ug. mycobactin/ml. of medium.
